Stock List

Search by Ticker



Stock Analysis


Stock Analysis

The following stock analysis is based on 9.7 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.

Stock Exchange

trades on the exchange in dollars.


It is in the healthcare sector.

Current Status of

It is currently trading at $ ($ the previous day).


The next reporting date is in 46 days (2023 07 27).

CNN estimates profits for the upcoming quarter will be $0.65 per share ($1.5B). The current Canada / US exchange rate is .

Over the past 12 months, $0 worth of shares have been purchased and $52685982 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is -100.0% per year assuming steady exponential growth. The actual 5 year average is 18.64. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year85.141645454545-24.3- Below Average
2 year112.5199218649535.8+ Above Average
3 year82.84801960784313.5- Below Average
4 year72.99934693877635.2+ Above Average
5 year53.9903435114533+ Above Average
is projected by analysts to get to $95.00 within the next 12 months (0%), but preticted targets range from as high as $105.00 (0%) and as low as $73(0%).


The worst drop it has had in recent years is -48.0%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.

Stock shape test



Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.

The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.

Tradingview BuySell Widget

Yahoo News Feed

Here's Why You Should Invest in Edward Lifesciences (EW) Now

Mon, 05 Jun 2023 11:26:00 Investors continue to be optimistic about Edward Lifesciences (EW) on the strength of the Surgical Structural Heart business and the Critical Care segment.... Read Full Article

Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction

Fri, 02 Jun 2023 14:54:21 Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human ...... Read Full Article

Edwards Lifesciences' (NYSE:EW) five-year total shareholder returns outpace the underlying earnings growth

Tue, 30 May 2023 11:00:30 Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can make...... Read Full Article

Edwards Lifesciences (EW) Down 5.9% Since Last Earnings Report: Can It Rebound?

Fri, 26 May 2023 15:31:28 Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.... Read Full Article

Edwards Lifesciences Corporation (NYSE:EW) Shares Could Be 35% Above Their Intrinsic Value Estimate

Fri, 26 May 2023 10:12:21 Key Insights Using the 2 Stage Free Cash Flow to Equity, Edwards Lifesciences fair value estimate is US$60.49 Edwards...... Read Full Article

Top Stock Reports for Home Depot, Linde and Walt Disney

Thu, 25 May 2023 21:10:00 Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Linde plc (LIN) and The Walt Disney Company (DIS).... Read Full Article

Edwards Lifesciences' (EW) TAVR Study Outcome Favorable

Thu, 18 May 2023 17:12:05 Edwards Lifesciences' (EW) latest findings of the study confirm the value of the Edwards Benchmark programme for standardizing clinical pathways for patients undergoing TAVR in Europe.... Read Full Article


Wed, 17 May 2023 08:30:00 Edwards Lifesciences (NYSE: EW) announced today that new data from the Benchmark Registry in Europe demonstrated the safety and effectiveness of this streamlined treatment pathway for patients receiving transcatheter aortic valve replacement (TAVR) with balloon-expandable valves. The data were presented ...... Read Full Article

ITGR vs. EW: Which Stock Is the Better Value Option?

Tue, 16 May 2023 15:40:03 ITGR vs. EW: Which Stock Is the Better Value Option?... Read Full Article

STERIS (STE) Q4 Earnings Beat Estimates, Gross Margin Falls

Fri, 12 May 2023 13:47:01 Heading into fiscal 2024, STERIS (STE) expects many of its fiscal 2023 challenges to abate, including procedure volumes and supply chain constraints.... Read Full Article

Haemonetics (HAE) Q4 Earnings and Revenues Top Estimates

Fri, 12 May 2023 12:32:12 Amid a challenging economic environment, Haemonetics (HAE) delivers impressive fiscal fourth-quarter organic revenues, led by the stellar performance across the Plasma and Hospital business.... Read Full Article

Alcon (ALC) Q1 Earnings Surpass Estimates, 23' EPS View Up

Thu, 11 May 2023 16:40:04 Alcon (ALC) Q1 revenues were driven by strong consumables and equipment sales.... Read Full Article

Here's Why You Should Retain Walgreens Boots (WBA) For Now

Thu, 11 May 2023 16:37:04 Investors are optimistic about Walgreens Boots (WBA) on consistent partnership growth and a strong focus on strategic execution.... Read Full Article

Charles River (CRL) Q1 Earnings Top Estimates, View Narrowed

Thu, 11 May 2023 15:42:03 Charles River (CRL) registers robust growth in small research models, research model services and the Cell Solutions business.... Read Full Article

NuVasive (NUVA) Q1 Earnings Beat Estimates, Margins Fall

Thu, 11 May 2023 15:26:03 NuVasive's (NUVA) strong sales across the U.S. Spinal Hardware and U.S. Surgical Support businesses instill optimism.... Read Full Article

Syneos Health (SYNH) Tops Q1 Earnings, Announces Merger Plan

Thu, 11 May 2023 13:19:01 Syneos Health's (SYNH) first-quarter 2023 earnings and revenues beat estimates. The company enters into a definitive merger agreement to be acquired by a private investment consortium.... Read Full Article

SmileDirectClub (SDC) Q1 Earnings Miss, Gross Margin Up

Wed, 10 May 2023 15:42:03 SmileDirectClub (SDC) Q1 revenues are affected by persistent macroeconomic headwinds.... Read Full Article

Exact Sciences (EXAS) Q1 Earnings Top, Sales View Raised

Wed, 10 May 2023 13:37:01 The upside in Exact Sciences' (EXAS) screening revenues is primarily coming from broad-based momentum in Cologuard adoption.... Read Full Article

Henry Schein (HSIC) Q1 Earnings Miss, Operating Margin Dips

Tue, 09 May 2023 15:03:03 Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.... Read Full Article

Omnicell's (OMCL) New Acquisitions Aid Growth, Cost Woes Stay

Tue, 09 May 2023 14:51:02 Omnicell (OMCL) remains well-positioned to meet pharmacy and hospital needs, backed by the recent acquisitions and expansion of its advanced services solutions.... Read Full Article